<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37195688</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>The Development of a Chatbot Technology to Disseminate Post-COVID-19 Information: Descriptive Implementation Study.</ArticleTitle><Pagination><StartPage>e43113</StartPage><MedlinePgn>e43113</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e43113</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/43113</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post-COVID-19, or long COVID, has now affected millions of individuals, resulting in fatigue, neurocognitive symptoms, and an impact on daily life. The uncertainty of knowledge around this condition, including its overall prevalence, pathophysiology, and management, along with the growing numbers of affected individuals, has created an essential need for information and disease management. This has become even more critical in a time of abundant online misinformation and potential misleading of patients and health care professionals.</AbstractText><AbstractText Label="OBJECTIVE">The RAFAEL platform is an ecosystem created to address the information about and management of post-COVID-19, integrating online information, webinars, and chatbot technology to answer a large number of individuals in a time- and resource-limited setting. This paper describes the development and deployment of the RAFAEL platform and chatbot in addressing post-COVID-19 in children and adults.</AbstractText><AbstractText Label="METHODS">The RAFAEL study took place in Geneva, Switzerland. The RAFAEL platform and chatbot were made available online, and all users were considered participants of this study. The development phase started in December 2020 and included developing the concept, the backend, and the frontend, as well as beta testing. The specific strategy behind the RAFAEL chatbot balanced an accessible interactive approach with medical safety, aiming to relay correct and verified information for the management of post-COVID-19. Development was followed by deployment with the establishment of partnerships and communication strategies in the French-speaking world. The use of the chatbot and the answers provided were continuously monitored by community moderators and health care professionals, creating a safe fallback for users.</AbstractText><AbstractText Label="RESULTS">To date, the RAFAEL chatbot has had 30,488 interactions, with an 79.6% (6417/8061) matching rate and a 73.2% (n=1795) positive feedback rate out of the 2451 users who provided feedback. Overall, 5807 unique users interacted with the chatbot, with 5.1 interactions per user, on average, and 8061 stories triggered. The use of the RAFAEL chatbot and platform was additionally driven by the monthly thematic webinars as well as communication campaigns, with an average of 250 participants at each webinar. User queries included questions about post-COVID-19 symptoms (n=5612, 69.2%), of which fatigue was the most predominant query (n=1255, 22.4%) in symptoms-related stories. Additional queries included questions about consultations (n=598, 7.4%), treatment (n=527, 6.5%), and general information (n=510, 6.3%).</AbstractText><AbstractText Label="CONCLUSIONS">The RAFAEL chatbot is, to the best of our knowledge, the first chatbot developed to address post-COVID-19 in children and adults. Its innovation lies in the use of a scalable tool to disseminate verified information in a time- and resource-limited environment. Additionally, the use of machine learning could help professionals gain knowledge about a new condition, while concomitantly addressing patients' concerns. Lessons learned from the RAFAEL chatbot will further encourage a participative approach to learning and could potentially be applied to other chronic conditions.</AbstractText><CopyrightInformation>&#xa9;Mayssam Nehme, Franck Schneider, Anne Perrin, Wing Sum Yu, Simon Schmitt, Guillemette Violot, Aurelie Ducrot, Frederique Tissandier, Klara Posfay-Barbe, Idris Guessous. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.06.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nehme</LastName><ForeName>Mayssam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9189-6495</Identifier><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Franck</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0008-5884-1343</Identifier><AffiliationInfo><Affiliation>Department of Communication, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrin</LastName><ForeName>Anne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2023-3157</Identifier><AffiliationInfo><Affiliation>Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sum Yu</LastName><ForeName>Wing</ForeName><Initials>W</Initials><Identifier Source="ORCID">0009-0005-4465-2590</Identifier><AffiliationInfo><Affiliation>Department of Communication, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0001-9473-3138</Identifier><AffiliationInfo><Affiliation>Department of Communication, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Violot</LastName><ForeName>Guillemette</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9017-1193</Identifier><AffiliationInfo><Affiliation>Department of Communication, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ducrot</LastName><ForeName>Aurelie</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0004-0494-6677</Identifier><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tissandier</LastName><ForeName>Frederique</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0006-5427-1748</Identifier><AffiliationInfo><Affiliation>Department of Communication, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posfay-Barbe</LastName><ForeName>Klara</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9464-5704</Identifier><AffiliationInfo><Affiliation>Division of General Pediatrics, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guessous</LastName><ForeName>Idris</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0491-6089</Identifier><AffiliationInfo><Affiliation>Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017753" MajorTopicYN="N">Ecosystem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">caregiver</Keyword><Keyword MajorTopicYN="N">chatbot</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">communication</Keyword><Keyword MajorTopicYN="N">conversational agent</Keyword><Keyword MajorTopicYN="N">digital surveillance</Keyword><Keyword MajorTopicYN="N">disease management</Keyword><Keyword MajorTopicYN="N">dissemination</Keyword><Keyword MajorTopicYN="N">information</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">medical technology</Keyword><Keyword MajorTopicYN="N">online platform</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">postacute sequelae of SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">post&#x2013;COVID-19</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37195688</ArticleId><ArticleId IdType="pmc">PMC10246662</ArticleId><ArticleId IdType="doi">10.2196/43113</ArticleId><ArticleId IdType="pii">v25i1e43113</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A clinical case defintion of post COVID-19 condition by a Delphi consensus. World Health Organization. 2021. Oct 6,  [2021-10-10].  
 https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-&#x200b;Clinical-case-definition-2021.1-eng.pdf
.</Citation></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I, CoviCare Study Team  Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021 Sep;174(9):1252&#x2013;1260. doi: 10.7326/M21-0878. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021 Feb 01;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830. 
 
2776560</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022 Apr 09;181(4):1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z. 
 
10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, Murray B, Kl&#xe4;ser K, Kerfoot E, Chen L, Deng J, Hu C, Selvachandran S, Read K, Capdevila Pujol J, Hammers A, Spector TD, Ourselin S, Steves CJ, Modat M, Absoud M, Duncan EL. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021 Oct;5(10):708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X. 
 
S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, Simmons R, Zavala M, O'Mahoney L, Chalder T, Crawley E, Ford TJ, Harnden A, Heyman I, Swann O, Whittaker E, CLoCk Consortium. Ladhani SN. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022 Apr;6(4):230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0. 
 
S2352-4642(22)00022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F, Nguyen V, Navaratnam A. Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales. medRxiv 2021;2021.05.28.2125. 2021:7602. doi: 10.1101/2021.05.28.21257602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.28.21257602</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont R, Richard V, Lorthe E. Post-COVID syndrome prevalence and risk factors in children and adolescents: a population-based serological study. medRxiv 2022;2022.08.24.22279150. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9708639</ArticleId><ArticleId IdType="pubmed">36446760</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, Guessous I, COVICARE TEAM  COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2021 May;174(5):723&#x2013;725. doi: 10.7326/M20-5926. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Kaiser L, Soccal PM, Reny J, Assal F, Bondolfi G, Tardin A, Graf C, Zekry D, Stringhini S, Spechbach H, Jacquerioz F, Salamun J, Lador F, Coen M, Agoritsas T, Benzakour L, Favale R, Genevay S, Lauper K, Meyer P, Poku NK, Landis BN, Baggio S, Grira M, Sandoval J, Ehrsam J, Regard S, Genecand C, Kopp G, Guerreiro I, Allali G, Vetter P, Guessous I, CoviCare Study Team  One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals. J Intern Med. 2022 Jul;292(1):103&#x2013;115. doi: 10.1111/joim.13482. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13482</ArticleId><ArticleId IdType="pmc">PMC9115262</ArticleId><ArticleId IdType="pubmed">35555926</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Aebischer Perone S, Guessous I, Lab B, Grira M, Beran D, Innaurato G, Carnino L, Sandoval JL, Vogel T, Socquet J, Chappuis F, Alcoba G, Braillard O. CoviCare. Swiss Med Forum. 2020 Jul 01;20(27-30):396&#x2013;399. doi: 10.4414/fms.2020.08550.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/fms.2020.08550</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 processes sharing platform: management and follow-up processes for ambulatory care centers handling COVID-19. CoviCare24.  [2021-09-29].  
 https://www.covicare24.com
.</Citation></Reference><Reference><Citation>Post-COVID, Post-acute sequelae of SARS-CoV-2. Guidelines for the management of patients with long-term sequelae of SARSCoV-2 infection. Geneva University Hospitals.  [2021-09-29].  
 https://www.hug.ch/sites/interhug/files/structures/coronavirus/guidelines-postcovid-pourmedecinstraitants.pdf
.</Citation></Reference><Reference><Citation>Long COVID consultation. Geneva University Hospitals.  [2021-09-29].  
 https://www.hug.ch/covid/long-covid
.</Citation></Reference><Reference><Citation>Long COVID in children. Geneva University Hospitals.  [2021-09-29].  
 https://www.hug.ch/pediatrie-generale/covid-long-chez-enfants
.</Citation></Reference><Reference><Citation>Amiri P, Karahanna E. Chatbot use cases in the Covid-19 public health response. J Am Med Inform Assoc. 2022 Apr 13;29(5):1000&#x2013;1010. doi: 10.1093/jamia/ocac014. 
 
6523926</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac014</ArticleId><ArticleId IdType="pmc">PMC8903403</ArticleId><ArticleId IdType="pubmed">35137107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bibault J, Chaix B, Guillemass&#xe9; A, Cousin S, Escande A, Perrin M, Pienkowski A, Delamon G, Nectoux P, Brouard B. A chatbot versus physicians to provide information for patients with breast cancer: blind, randomized controlled noninferiority trial. J Med Internet Res. 2019 Nov 27;21(11):e15787. doi: 10.2196/15787. 
 
v21i11e15787</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/15787</ArticleId><ArticleId IdType="pmc">PMC6906616</ArticleId><ArticleId IdType="pubmed">31774408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaix B, Bibault J, Pienkowski A, Delamon G, Guillemass&#xe9; Arthur, Nectoux P, Brouard B. When chatbots meet patients: one-year prospective study of conversations between patients with breast cancer and a chatbot. JMIR Cancer. 2019 May 02;5(1):e12856. doi: 10.2196/12856. 
 
v5i1e12856</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/12856</ArticleId><ArticleId IdType="pmc">PMC6521209</ArticleId><ArticleId IdType="pubmed">31045505</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Sanders L, Li K, Chow JCL. Chatbot for health care and oncology applications using artificial intelligence and machine learning: systematic review. JMIR Cancer. 2021 Nov 29;7(4):e27850. doi: 10.2196/27850. 
 
v7i4e27850</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/27850</ArticleId><ArticleId IdType="pmc">PMC8669585</ArticleId><ArticleId IdType="pubmed">34847056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor Car L, Dhinagaran DA, Kyaw BM, Kowatsch T, Joty S, Theng Y, Atun R. Conversational agents in health care: scoping review and conceptual analysis. J Med Internet Res. 2020 Aug 07;22(8):e17158. doi: 10.2196/17158. 
 
v22i8e17158</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/17158</ArticleId><ArticleId IdType="pmc">PMC7442948</ArticleId><ArticleId IdType="pubmed">32763886</ArticleId></ArticleIdList></Reference><Reference><Citation>Schario ME, Bahner CA, Widenhofer TV, Rajaballey JI, Thatcher EJ. Chatbot-assisted care management. Prof Case Manag. 2022;27(1):19&#x2013;25. doi: 10.1097/NCM.0000000000000504.01269241-202201000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NCM.0000000000000504</ArticleId><ArticleId IdType="pubmed">34846321</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S, Kim J, Kim S, Hong J, Kim S, Kim E. Mobile app-based chatbot to deliver cognitive behavioral therapy and psychoeducation for adults with attention deficit: a development and feasibility/usability study. Int J Med Inform. 2021 Jun;150:104440. doi: 10.1016/j.ijmedinf.2021.104440.S1386-5056(21)00066-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2021.104440</ArticleId><ArticleId IdType="pubmed">33799055</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin AC, Xing Z, Khairat S, Wang Y, Bailey S, Arguello J, Chung AE. Conversational agents for chronic disease self-management: a systematic review. AMIA Annu Symp Proc. 2020;2020:504&#x2013;513. 
 
084_3410598</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075433</ArticleId><ArticleId IdType="pubmed">33936424</ArticleId></ArticleIdList></Reference><Reference><Citation>Welle K. Conversations with chatbots: helping people in the DRC access multilingual COVID-19 information. Translators without Borders.  [2022-05-28].  
 https://translatorswithoutborders.org/blog/chatbot-uji-drc/
</Citation></Reference><Reference><Citation>Alwan NA. Lessons from Long COVID: working with patients to design better research. Nat Rev Immunol. 2022 Apr;22(4):201&#x2013;202. doi: 10.1038/s41577-022-00692-6. 
 
10.1038/s41577-022-00692-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00692-6</ArticleId><ArticleId IdType="pmc">PMC8853146</ArticleId><ArticleId IdType="pubmed">35169259</ArticleId></ArticleIdList></Reference><Reference><Citation>RAFAEL, the post-COVID information platform. Geneva University Hospitals.  [2023-05-18].  
 https://rafael-postcovid.ch
.</Citation></Reference><Reference><Citation>Sharma V, Goyal M, Malik D. An intelligent behaviour shown by chatbot system. Int J New Technol Res. 2017 Apr;3(4):52&#x2013;54. doi: 10.31871/ijntr.</Citation><ArticleIdList><ArticleId IdType="doi">10.31871/ijntr</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;pos&#xe9; f&#xe9;d&#xe9;ral &#xe0; la protection des donn&#xe9;es et &#xe0; la transparence (PFPDT). Le r&#xe8;glement g&#xe9;n&#xe9;ral de l'Union Europ&#xe9;enne sur la protection des donn&#xe9;es. Conf&#xe9;d&#xe9;ration Suisse.  [2022-09-29].  
 https://www.edoeb.admin.ch/edoeb/fr/home/documentation/datenschutz/Datenschutz%20-%20International/DSGVO.html
.</Citation></Reference><Reference><Citation>RAFAEL?: Tout savoir sur les sympt&#xf4;mes post-COVID. Geneva University Hospitals. 2021. Nov 17,  [2022-02-27].  
 https://www.hug.ch/medias/communique-presse/plateforme-rafael-tout-savoir-sur-symptomes-post-covid
.</Citation></Reference><Reference><Citation>Kim T, Kang JW, Jeon S, Ang L, Lee HW, Lee MS. Use of traditional, complementary and integrative medicine during the COVID-19 pandemic: a systematic review and meta-analysis. Front Med (Lausanne) 2022;9:884573. doi: 10.3389/fmed.2022.884573. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.884573</ArticleId><ArticleId IdType="pmc">PMC9125211</ArticleId><ArticleId IdType="pubmed">35615091</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna NN, Maindarkar MA, Viswanathan V, Fernandes JFE, Paul S, Bhagawati M, Ahluwalia P, Ruzsa Z, Sharma A, Kolluri R, Singh IM, Laird JR, Fatemi M, Alizad A, Saba L, Agarwal V, Sharma A, Teji JS, Al-Maini M, Rathore V, Naidu S, Liblik K, Johri AM, Turk M, Mohanty L, Sobel DW, Miner M, Viskovic K, Tsoulfas G, Protogerou AD, Kitas GD, Fouda MM, Chaturvedi S, Kalra MK, Suri JS. Economics of artificial intelligence in healthcare: diagnosis vs. treatment. Healthcare (Basel) 2022 Dec 09;10(12):2493. doi: 10.3390/healthcare10122493. 
 
healthcare10122493</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10122493</ArticleId><ArticleId IdType="pmc">PMC9777836</ArticleId><ArticleId IdType="pubmed">36554017</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer J, Lehne M, Schepers J, Prasser F, Thun S. The use of machine learning in rare diseases: a scoping review. Orphanet J Rare Dis. 2020 Jun 09;15(1):145. doi: 10.1186/s13023-020-01424-6. 
 
10.1186/s13023-020-01424-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01424-6</ArticleId><ArticleId IdType="doi">10.1186/s13023-020-01424-6</ArticleId><ArticleId IdType="pmc">PMC7285453</ArticleId><ArticleId IdType="pubmed">32517778</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahum-Shani I, Smith SN, Spring BJ, Collins LM, Witkiewitz K, Tewari A, Murphy SA. Just-in-time adaptive interventions (JITAIs) in mobile health: key components and design principles for ongoing health behavior support. Ann Behav Med. 2018 May 18;52(6):446&#x2013;462. doi: 10.1007/s12160-016-9830-8. 
 
10.1007/s12160-016-9830-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12160-016-9830-8</ArticleId><ArticleId IdType="pmc">PMC5364076</ArticleId><ArticleId IdType="pubmed">27663578</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>